Jeff Knox is a principal at Innospark Ventures focused on AI applications in biotech and hard sciences. He previously consulted for biopharma and digital health companies and led Nucleate's Boston chapter.
At firms with a similar stage, sector and check size.
One email when Jeff's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJeff Knox is a principal at Innospark Ventures focused on AI applications in biotech and hard sciences. He previously consulted for biopharma and digital health companies and led Nucleate's Boston chapter.
Jeff Knox invests through Innospark Ventures, which writes checks of $250K to $3M at pre-seed, seed.
A warm intro from a founder Innospark Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
Managing Director at Nucleate; Managing Director of founding Boston chapter at Nucleate.
Last updated 2026-10-15. Is this you? Ask for a correction.